Regeneron Data Breach Exposes Sensitive Patient Info

The February 2024 Data Breach

On February 21, 2024, Regeneron Pharmaceuticals, Inc. experienced a significant data breach involving unauthorized access to one of its third party vendors, Cencora, Inc. and its Lash Group affiliate. The breach was detected and subsequently investigated with the aid of law enforcement and cybersecurity experts. It was confirmed on April 10, 2024, that personal information had indeed been compromised.

Information Exposed

During this breach, several types of sensitive consumer information were exposed, including:

• First name
• Last name
• Address
• Date of birth
• Health diagnosis
• Medications and prescriptions

Steps to Take if You Are Affected

If your information was compromised in this breach, it is crucial to remain vigilant and take steps to protect your identity. Here are some recommended actions:

• Enroll in the offered credit monitoring service to receive alerts about any suspicious activities related to your credit.
• Review your financial statements and reports regularly for any unauthorized transactions or discrepancies.
• Place a fraud alert on your credit reports by contacting one of the major credit bureaus (Equifax, Experian, or TransUnion).
• Consider placing a security freeze on your credit files, which restricts access to your credit report and helps prevent new credit accounts from being opened in your name.

For detailed instructions on how to enroll in Experian IdentityWorksSM and other protective measures, please refer to the Notice to Consumers provided by Regeneron Pharmaceuticals, Inc.

By taking the steps outlined above and staying informed, you can help safeguard your personal information and respond effectively to potential threats resulting from this data breach.